PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
Condition(s):NK-T-Cell Lymphoma, ExtranodalLast Updated:October 6, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):NK-T-Cell Lymphoma, ExtranodalLast Updated:October 6, 2023Not yet recruiting
Condition(s):Peripheral T Cell LymphomaLast Updated:August 5, 2016Unknown status
Condition(s):T Cell LymphomaLast Updated:November 4, 2015Unknown status
Condition(s):Autologous Stem Cell Transplantation; ConditioningLast Updated:April 18, 2023Not yet recruiting
Condition(s):NK/T Cell Lymphoma NosLast Updated:May 7, 2020Unknown status
Condition(s):T-cell Non-Hodgkin Lymphoma; Lymphoma, Extranodal NK-T-CellLast Updated:August 18, 2022Recruiting
Condition(s):Extranodal NK/T-cell Lymphoma, Nasal TypeLast Updated:March 5, 2013Terminated
Condition(s):Peripheral T-cell LymphomaLast Updated:October 29, 2021Completed
Condition(s):Peripheral T Cell LymphomaLast Updated:March 3, 2021Unknown status
Condition(s):Extranodal Natural Killer T Cell LymphomaLast Updated:February 13, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.